Document Detail

Clinical utility of natriuretic peptides in left ventricular failure.
MedLine Citation:
PMID:  23380756     Owner:  NLM     Status:  In-Data-Review    
ABSTRACT: Left ventricular failure (LVF) is a clinical syndrome caused by abnormal systolic or diastolic function failing to meet the metabolic requirements of the body. It is important to diagnose and manage LVF in the earliest stages to prevent mortality and morbidity. This article extensively reviews the diagnostic, therapeutic, and prognostic utility of natriuretic peptides in LVF.
Pramod Reddy; Rohan Samson
Related Documents :
20514436 - Increased expression of calpain and elevated activity of calcineurin in the myocardium ...
12374896 - Effects of canrenone on myocardial reactive fibrosis in a rat model of postinfarction h...
16445726 - Collagen fiber morphology determines echogenicity of myocardial scar: implications for ...
19027736 - Interventional effect of valsartan on expression of inducible camp early repressor and ...
16215686 - Nitrate tolerance aggravates postischemic myocardial apoptosis and impairs cardiac func...
8035346 - Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin i-convertin...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Southern medical journal     Volume:  106     ISSN:  1541-8243     ISO Abbreviation:  South. Med. J.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-02-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0404522     Medline TA:  South Med J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  182-7     Citation Subset:  AIM; IM    
From the Department of Medicine, University of Florida College of Medicine, Jacksonville.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Well-child care in infancy and healthcare services utilization from birth to 6 years by late preterm...
Next Document:  microRNA-16 represses colorectal cancer cell growth in vitro by regulating the p53/survivin signali...